Editors of Advanced Drug Delivery Reviews
@ADDReditors
Followers
3K
Following
140
Media
700
Statuses
2K
Via this account, the editors of Advanced Drug Delivery Reviews share new publications. Likes/retweets/follows do not endorse any particular viewpoint.
Joined May 2019
ADDR Open Access: Advanced adhesion and targeting strategies to prolong gut residence time and improve eLBP efficacy in colonic diseases. By Juliane Nguyen & coworkers @DPMP_UNC
#GutResidence #adhesion #ColonicDisease
https://t.co/gkvugDfygn
0
0
2
ADDR Open Access: Toward pharmaceutical selective laser sintering 3D printing-a thermal and temperature-dependent analysis perspective. By Piotr Kulinowski & coworkers, Univ. of the National Education Commission #3Dprinting #preformulation
https://t.co/58c3PLy652
0
0
2
ADDR 50 days' free access: Investigating the restriction-modification barrier to DNA delivery in human gut probiotic bacteria for streamlined genetic tool development. By Justin M. Vento & coworkers @NovaEngineer
#DNAdelivery #probiotic
https://t.co/T47kcRJPk1
0
0
0
ADDR 50 days' free access: The complex and intricate relationship between incremental science, innovation and recognition. By David W. Grainger & coworkers @PHCEUutah
#ResearchValidation #translation
https://t.co/4pzIpQK7au
0
0
1
ADDR Open Access: Composition, stabilization and delivery of virus-based vaccines: considerations to break free of the cold chain. By Maria A. Croyle & coworkrs @UTexasPharmacy
#vaccine #stabiliy
https://t.co/en54whrm2Q
0
2
2
ADDR 50 days' free access: Nitric oxide-modulating biomaterials for therapeutic Immunoengineering. By Won Jong Kim & coworkers, POSTECH @KoreaCRS
#NitricOxide #immunoengineering
https://t.co/WZtCu3hfSW
0
0
1
ADDR 50 days' free access: Hydrogen sulfide in cancer therapy: Intelligent delivery platforms and synergistic therapeutic paradigms. By Liang Cheng & coworkers, Macau Univ. of Science and Technology #HydrogenSulfide #GasTherapy
https://t.co/1A7mjqPp2e
0
0
0
ADDR 50 days' free access: Opportunities for machine learning and artificial intelligence in physiologically-based pharmacokinetic (PBPK) modeling. By Samuel K. Lai & coworkers @DPMP_UNC
#MachineLearning #ArtificialIntelligence #pharmacokinetic
https://t.co/qMqAgEl9tz
0
0
1
ADDR Open Access: iPSC-derived T cells and macrophages: Manufacturing and next-generation application approaches. By Nico Lachmann & coworkers, Hannover Medical School @CRS_DeChAt_LC
#iPSC #Tcell #macrophage #manufacturing
https://t.co/0Ig5Q9IxRe
0
1
2
ADDR 50 days' free access: Cold atmospheric plasma for gas therapy and gas-activated drug delivery. By Jaiwoo Lee & coworkers, Korea Univ. @Jaiwoo_Lee_Kor @KoreaCRS
#ColdAtmosphericPlasma #GasTherapy
https://t.co/ulMJBGQxuw
0
0
1
The interplay between Glioblastoma and its microenvironment with the Blood-Brain Barrier are now discussed @ADDReditors in the context of cutting-edge, predictive value in vitro BBB–GBM models. https://t.co/8WU2yiABzs
#Glioblastoma #CancerResearch #DrugDelivery #i3S_Papers
0
1
2
ADDR 50 days' free access: Recent advances in gene delivery for melanocyte-associated disorders. By Hamidreza Ghandehari & coworkers @H_Ghandehari @PHCEUutah
#GeneDelivery #melanocyte
https://t.co/gxNfpAGvAS
0
3
5
ADDR Open Access: Repurposing the bacterial surface display technology for drug delivery. By Jiahe Li & coworkers @UMBME
#SyntheticBiology #microbiome
https://t.co/hgHRll85Q4
0
1
4
ADDR Open Access: 20 years of flash nanoprecipitation – from controlled precipitation to global medicine. By Nathalie M. Pinkerton & coworkers @nyutandon
#nanoprecipitation #manufacturing
https://t.co/hT0hDyrkqe
0
0
2
ADDR Open Access: In vitro models of the interplay between glioblastoma and blood–brain barrier for stratifying drug efficacy. By Bruno Sarmento & coworkers @i3S_UPorto @brunocsarmento @CRS_SPLC
#BloodBrainBarrier #CellInterplay #InVitroModel
https://t.co/dtQ4hzktD7
0
1
8
ADDR 50 days' free access: Drug delivery strategies for paediatric diffuse midline gliomas. By Andrew L. Lewis & coworkers, Quotient Science @UKICRS
#intranasal #intrathecal #PaediatricGlioma
https://t.co/GIqZ0hWUN3
0
0
1
ADDR 50 days' free access: Aptamers as New Frontier in Targeted Cancer Therapy. By Xue-Qiang Wang & coworkers, Hangzhou Institute of Medicine #aptamer
https://t.co/IVFuHTB5JR
0
0
0
ADDR 50 days' free access: Recent advances in intelligent oxygen delivery systems for tissue regeneration. By Jinhui Wu & coworkers @NanjingUnivers1
#OxygenDelivery #TissueRegeneration
https://t.co/M1jgSwtvNg
0
0
1
[Perspective] ADDR Open Access: Optical technologies in monitoring mobility and delivery of drugs and metabolic agents. By Valery V. Tuchin, Tianhong Dai, Luís M. Oliveira #OpticalTechnology #monitoring #DrugDelivery
https://t.co/qcDarP8omQ
0
0
0
ADDR Open Access: Sonodynamic therapy: transforming sound into light for hard-to-treat tumours. By Maya Thanou @KingsCollegeLon @UKICRS
#sonodynamic #microbubble #ultrasound
https://t.co/XGVS83GZKR
0
0
1